http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2013DE02954-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91305a1295a2b3746a189db0e156064c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89de70a3227e3dfcd42618b356a919db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4c66b4fe3cfb8693587ea3ef76e403f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fbaa6589e018a022e3e6e833f643ae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6415840e16956cb6a2f01881597d1252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8605e1b6d533aeaa32300a5bb095fd0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad75ad310c92ebb75a90aa9d9a568f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a08563601a84c1ddaa280fbb5b37d974
publicationDate 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IN-2013DE02954-A
abstract The present invention relates to newer generaration of triazoles, tetrazoles, isoxazoles, urea and sulphonamide functionalities containing 6-nitro-2, 3-dihydronitroimidazooxazoles agents, their method of preparation, and to their use as drugs for treating Mycobacterium tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents. In the present invention, new generaration 6-nitro-2,3-dihydronitroimidazooxazoleasg ents also shown acceptable pharmacokinetic properties and synergistic or additive effects with known anti-tubercular drugs.
priorityDate 2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117993836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433029319

Total number of triples: 30.